(Q57400056)

English

Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder

article by Stephen Faraone published June 2008 in Expert Opinion on Pharmacotherapy

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder (English)

0 references

main subject

attention deficit hyperactivity disorder

0 references

1 reference

Stephen V Faraone

1

0 references

language of work or name

English

0 references

publication date

June 2008

0 references

published in

Expert Opinion on Pharmacotherapy

0 references

volume

9

0 references

issue

9

0 references

page(s)

1565-1574

0 references

cites work

Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Attention-deficit hyperactivity disorder

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

What is the prevalence of adult ADHD? Results of a population screen of 966 adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

The neuropsychopharmacology of attention-deficit/hyperactivity disorder

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

History and current perspectives on the use of drug formulations to decrease the abuse of prescription drugs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Long-Term Effects of Methylphenidate Transdermal Delivery System Treatment of ADHD on Growth

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.9.9.1565

retrieved

21 January 2018

Identifiers

DOI

10.1517/14656566.9.9.1565

0 references

PubMed publication ID

18518785

0 references

(Q57400056)

Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)